Product Description
Anti-ERBB2 (Trastuzumab-LC-E161) -DBCO-MMAF ADC | ADC-W-257 | Creative Biolabs
Short Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody (Trastuzumab variant, LC-E161) conjugated via a DBCO linker to MMAF
Status: In stock
Expected Delivery Time: 9-11Weeks